Oyster Point Pharma Inc (OYST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 09-2018 | 06-2018 | 12-2017 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | N/A | N/A | N/A | 22,311 |
| Other current assets | 0 | 0 | 0 | 863 |
| TOTAL | $N/A | $N/A | $N/A | $23,174 |
| Non-Current Assets | ||||
| TOTAL | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $N/A | $N/A | $N/A | $23,174 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 418 |
| Accrued Expenses | N/A | N/A | N/A | 1,649 |
| TOTAL | $N/A | $N/A | $N/A | $2,067 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 43,001 |
| TOTAL | $N/A | $N/A | $N/A | $43,001 |
| Total Liabilities | $N/A | $N/A | $N/A | $45,068 |
| Shareholders' Equity | ||||
| Common Shares | N/A | N/A | N/A | 1 |
| Retained earnings | N/A | N/A | N/A | -22,017 |
| TOTAL | $N/A | $N/A | $N/A | $-21,894 |
| Total Liabilities And Equity | $0 | $0 | $0 | $23,174 |